Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa)
© Soh et al.; licensee Springer. 2015
Received: 15 May 2014
Accepted: 22 January 2015
Published: 28 March 2015
We expressed the heat-labile enterotoxin B (LTB) subunit from enterotoxigenic Escherichia coli and the cholera toxin B (CTB) subunit from Vibrio cholerae under the control of the rice (Oryza sativa) globulin (Glb) promoter. Binding of recombinant LTB and CTB proteins was confirmed based on GM1-ganglioside binding enzyme-linked immunosorbent assays (GM1-ELISA). Real-time PCR of three generations (T3, T4, and T5) in homozygous lines (LCI-11) showed single copies of LTB, CTB, bar and Tnos. LTB and CTB proteins in rice transgenic lines were detected by Western blot analysis. Immunogenicity trials of rice-derived CTB and LTB antigens were evaluated through oral and intraperitoneal administration in mice, respectively. The results revealed that LTB- and CTB-specific IgG levels were enhanced in the sera of intraperitoneally immunized mice. Similarly, the toxin-neutralizing activity of CTB and LTB in serum of orally immunized mice was associated with elevated levels of both IgG and IgA. The results of the present study suggest that the combined expression of CTB and LTB proteins can be utilized to produce vaccines against enterotoxigenic strains of Escherichia coli and Vibrio cholera, for the prevention of diarrhea.
KeywordsOryza sativa Enterotoxin Transgenic plant Oral vaccine Immunogenicity
Enterotoxigenic Escherichia coli (ETEC) and Vibrio cholerae cause diarrhea by colonizing the small intestine and producing enterotoxins. The heat-labile enterotoxin B (LTB) produced by E. coli and the cholera toxin B subunit (CTB) produced by Vibrio cholerae are similar in structure, function and immunogenicity. LTB and CTB comprise a 27-kDa A subunit with ADP ribosyl transferase activity and a pentamer of 11.6-kDa B-binding subunits. The LTB and CTB subunits bind to GM1-ganglioside (galactosyl-N-acetylgalactosamyl-syalil-galactosylglucosylceramide) receptors on intestinal epithelial cells. Binding of LTB and CTB subunits allows a portion of the toxic A subunit to enter the cytosol, initiating a series of cellular events leading to diarrhea (Williams et al. 1999). CTB is applied as an oral vaccine against cholera, and immune responses against CTB are thought to prevent the toxic A subunit from entering host cells (Clemens et al. 1991). LTB forms a 60-kDa pentamer that facilitates binding to the GM1-ganglioside receptors on host epithelial cells, allowing the LTA (heat-labile enterotoxin A subunit) to endocytose and cause toxicity (Mason et al. 1998).
The production of recombinant proteins, such as biopharmaceuticals and vaccines, is commonly performed using bacterial, yeast and mammalian cell expression systems (Wurm 2004; Sue et al. 2005; Terpe 2006; Chen 2012; Mattanovich et al. 2012; Tingfeng et al. 2013). Recombinant proteins used in vaccines are glycosylated; bacteria do not glycosylate proteins, while yeasts may hyper-glycosylate proteins and show poor expression (Prokop et al. 1991; Archer 1994; Harashima 1994). The production of vaccines in microorganisms requires large-scale fermenters and stringent purification steps to obtain sufficient amounts of recombinant protein (Schonberger et al. 1991; Lebens et al. 1993). Similarly, mammalian cell cultures are expensive, hindering production of large quantities of vaccines. The development of various plant expression systems has enabled the expression of foreign antigens in plant tissue as edible vaccine vehicles (Haq et al. 1995; Du et al. 2005; El Adab et al. 2007; Ko et al. 2009; Sim et al. 2009; Unni and Soniya 2010; Cui et al. 2011; Guo et al. 2012). Plant-based edible vaccines offer advantages of longer shelf-life, stability at room temperature without loss of immunogenicity, and reduced production costs (Streatfield et al. 2001). Plant systems also ensure correct protein folding and eukaryotic post-translational modifications, with relatively high protein yield compared with other expression systems. Recently, enterotoxins have been expressed in several plant species. CTB has been expressed in a number of plant species, including potato (Arakawa et al. 1997), tomato (Jani et al. 2002), tobacco (Jani et al. 2004), carrot (Kim et al. 2009), rice (Oszvald et al. 2008; Kajiura et al. 2013), and maize (Karaman et al. 2012). Similarly, LTB was expressed in transgenic tobacco (Kang et al. 2003; Kim et al. 2011), rice callus (Kim et al. 2010) and carrot (Rosales-Mendoza et al. 2007, 2008), including the hairy roots of Solanaceous species (Guzman et al. 2011), and transgenic lettuce (Kim et al. 2007). However, the majority of plant expression systems pose challenges for vaccine production. For example, the production of vaccines in tobacco requires costly purification processes due to the presence of toxic alkaloid by-products (Ma et al. 2003).
The production of edible vaccines in seeds is attractive due to accumulation of storage proteins in relatively small volumes, and provision of stable dry environments that allow a high level of recombinant protein production. The advantages of rice include the high grain yield, ease of transformation, high stability, and ease of scale-up. Furthermore, rice is a self-pollinating plant with a low risk of unintended gene flow. Studies on rice as bioreactors have focused on utilizing its potential as an efficient oral vaccine delivery system (Yang et al. 2008). To date, several researchers have reported use of rice seed for the production of CTB (Nochi et al. 2007; Kajiura et al. 2013; Yuki et al. 2013).
Serum from CTB-immunized individuals does not neutralize LT as effectively as it neutralizes CT, and LTB and CTB show significant immunological cross-reactivity (Ahrén et al. 1993). Many studies suggested that the combined expression of CTB and LTB would be an excellent option to induce the individual’s immunization against ETEC and V. cholera because of the similar mechanism of action of CTB and LTB (Svennerholm et al. 1983; Svennerholm et al. 1986; Lebens et al. 1996). Despite the importance, there were no reports available on the combined expression of CTB and LTB proteins in rice. Hence, in the present study, CTB and LTB were produced together in rice grains using recombinant DNA technology. The CTB and LTB transgene expression level was monitored from third to fifth generations (T3-T5), and the in vivo immunogenicity of rice-derived CTB and LTB was evaluated in mice following oral and intraperitoneal administration. Our findings support the fact that the combined expression of CTB and LTB proteins can be utilized in producing vaccines against ETEC and V. cholera to treat diarrhea.
Transformation and analysis of third-generation homozygous transgenic rice
RT-PCR analysis revealed LTB- and CTB-specific transcripts in total RNA extracted from transformed rice seeds (Figure. 2d). The amplification products corresponded to a specific major transcript of the expected size of the transgene (lanes 2 to 8). No bands were observed for PCR products of untransformed plants used as negative controls (lane 1). The internal control was actin-1, with a PCR product of 150 bp.
Characteristics of transgenic rice lines
Chr. From #
Chr. To #
Molecular analysis of third- to fifth- generations (T3–5) plants
GM1-ganglioside receptor binding assay of LTB and CTB proteins
LTB- and CTB-specific serum and feces IgG and IgA levels after mouse immunization
Cholera and diarrheal diseases caused by enterotoxigenic Escherichia coli (ETEC) and V. cholerae are major global health problems. Cholera is the most severe ETEC infection, causing a large number of cases each year (Notaro and Kaper 1998). Effective vaccines could confer protection against these diseases by inducing an immune response and inhibiting enterotoxin activity. Immune-response-inducing toxins such as LTB and CTB are currently used as oral vaccines against diarrheal diseases. However, the production of these vaccines is expensive and requires stringent purification steps and delivery. Previously, several groups have demonstrated the production and oral immunogenicity of CTB and LTB in diverse transgenic plants (Jani et al. 2004; Rosales-Mendoza et al. 2008; Kim et al. 2009; Kajiura et al. 2013; Karaman et al. 2012; Yuki et al. 2013). Although several plant species are used for production of edible vaccines, seed crops—such as maize, wheat, or rice—are the most suitable. Among them, the use of transgenic rice for vaccine production offers several advantages over other plants. The benefits of producing edible vaccines in rice seeds include the production of large amounts of vaccine antigen for immunization, extended storage times at room temperature, and effective delivery of the vaccine to mucosal tissues.
Results from the present study indicate the potential for vaccine production in rice, an important cereal crop. In the current study, we focused on expressing CTB and LTB proteins in rice (Oryza sativa. L). A total of 25 putative transgenic rice plants showed the presence of CTB, LTB and bar genes, and plants were designated T0. The T0 plants harbored single and multiple copies of the LTB gene, as determined by Southern blotting. Expression levels of LTB and CTB proteins in grains were determined based on ganglioside-dependent ELISA. Levels of both proteins increased when compared to the BSA standard (Figure 5a). LTB and CTB from transgenic rice seeds accounted for up to 3.4 ng and 21.3 ng μg−1 per the total soluble protein, respectively. Enhanced CTB and protein levels were reported previously in cereal crops, at up to 0.05 μg in maize (Karaman et al. 2012) and 30 μg and 2.35 mg in rice (Dong et al. 1996; Kajiura et al. 2013). Similarly, LTB levels were reported to be 3.7% (Chikwamba et al. 2002) and 1.8% (Streatfield et al. 2002) in maize. Western blot analyses using an anti-CTB polyclonal antibody showed a molecular mass of 55 kDa. Previous studies reported a similar size, which was attributed to the pentameric structure (Nochi et al. 2007; Karaman et al. 2012). The CTBs expressed in rice were in their native pentameric form and were functionally active in terms of inducing antigen-specific immune responses.
Furthermore, intraperitoneal and oral immunization of mice with transgenic rice expressing LTB and CTB induced both systemic (IgG) and mucosal (IgA) immune responses (Figure 6a, b). Administration of 100-μg rice-expressed LTB and CTB administered IP was sufficient to induce LTB- and CTB-specific IgG production (Figure 6a). The levels of LTB- and CTB-specific IgG following IP administration in mice were similar. Furthermore, oral immunization of mice with LTB induced both systemic and mucosal IgA production. These findings are in agreement with previous reports of rice-expressed CTBs (Nochi et al. 2007; Yuki and Kiyono 2009; Tokuhara et al. 2010; Yuki et al. 2013). Systemic LTB- and CTB-specific IgG levels were similar in orally immunized mice (Figure 6b). However, production of low levels of CTB-specific IgG in orally immunized mice with maize-derived CTB mixed with maize-derived LTB suggested that LTB-specific IgG cross-reacted with CTB IgG, while CTB-specific IgG did not (Karaman et al. 2012). The level of LTB-specific mucosal IgA was increased compared to that of CTB-specific IgA. Moreover, feeding of maize-derived LTB resulted in significantly higher serum levels of LTB-specific IgA, suggesting that the maize-synthesized LTB was stable in maize tissues and was likely released slowly during digestion by LTB-immunized mice (Chikwamba et al. 2002).
Overall, these results suggest that the induction of systemic and mucosal immunity is enhanced by the combined administration of LTB and CTB, which strengthens the immune response in mice. CTB and LTBs expressed in corn (Tacket et al. 2004), maize (Karaman et al. 2012) and rice seeds (Nochi et al. 2007; Yuki et al. 2013) alone or in combination have been used to evaluate the use of corn as an edible agent against cholera and traveler’s diarrhea. The synergistic action of CTB and LTB in seeds could be enhanced by further breeding to advanced generations. In this study, we transformed rice capable of synthesizing detectable amounts of fused CTB and LTB subunit protein. This rice-based vaccine can be used as a combined vaccination system effective against both CT-based cholera and LT-based traveler’s diarrhea. The immunogenic and adjuvant abilities of the LTB and CTB proteins using mucosal immunization should be further evaluated in animal studies.
In this study, we transformed rice capable of synthesizing detectable amounts of CTB and LTB subunit proteins. This can be used as a combined vaccine effective against both CT-mediated cholera and LT-mediated traveler’s diarrhea. The immunogenic and adjuvant abilities of the LTB and CTB proteins using mucosal immunization should be further evaluated in animal studies.
Materials and methods
Reagents and apparatus
Murashige and Skoog (MS) medium, spectinomycin, and sucrose were purchased from MB cell (CA, U.S.A). Tetracycline, cefotaxime and phosphinothricin were purchased from Duchefa (Haarlem, Netherlands). The pMJ103 vector was constructed by GreenGene BioTech (Yongin, Korea) and the plasmids (MYO51, MYO53) containing LTB and/or CTB were kindly donated from Dr. M.S. Yang (Chonbuk National University). T4 DNA ligase and restriction endonucleases were obtained from Roche (Basel, Switzerland). Gateway BP and LR recombinase systems were purchased from Invitrogen (Breda, Netherlands). A mini trans-blot cell and Mini-Protean III cell were purchased from Bio-Rad (Hercules, CA, USA). Reagents for SDS-polyacrylamide electrophoresis, such as acrylamide, bis-acrylamide, ammonium persulfate, TEMED, prestained molecular weight markers and Coomassie Brilliant Blue R-250 solution were obtained from Bio-Rad (Hercules, CA, USA). Anti-LTB polyclonal antibody was obtained from Abcam (Cambridge, MA, USA). GM1-ganglioside and anti-rabbit IgG-conjugated alkaline phosphatase were purchased from Santa-Cruz Biotechnology (CA, USA). Thiamine-HCl, myo-inositol, anti-CTB polyclonal antibody, and other reagents such as salts and buffer components were of analytical grade and purchased from Sigma (St. Louis, MO, USA).
Two PCR fragments encoding the codon-optimized LTB gene (GenBank accession number: DI119695, 396 bp) and codon-optimized CTB gene (GenBank accession number: DI120788, 396 bp) were cloned into the pSB11 vector. Subsequently, using the Gateway BP and LR recombinase reactions, LTB (396 bp) and CTB (396 bp) fragments were cloned into the pMJ103 destination vector, including a globulin promoter (Glb), two recombination sites (attB1 and attB2), and a potato protease inhibitor II terminator (PinII). These constructed over-expression binary vectors were named pMJ103-LTB-CTB. To confirm the insertion of the LTB and/or CTB genes in pMJ103-LTB-CTB, the overexpression binary vector was digested by Not I (30 units/μl, Takara) for 1 h at 37°C. The restriction-digested products were analyzed by 1% agarose gel electrophoresis. Correct transfer of the LTB and CTB fragments and the presence of Glb and Pin II border regions in each vector were confirmed by DNA sequencing.
The Agrobacterium-mediated transformation of rice (Oryza sativa cv. Ilmi) was performed as described previously (Dong et al. 1996) with minor modifications. Briefly, embryogenic callus formation was induced by placing the mature embryos (scutellum side up) in 2 N6 [Chu N6 medium (MB cell, CA, U.S.A) supplemented with 2 mg L−1 2,4-D, 30 g L−1 sucrose, 0.5 g L−1 proline, 0.5 g L−1 glutamine, 0.3 g L−1 casamino acids, and solidified with 2.5 g L−1 Phytagel (Sigma, MO, U.S.A)] at pH 5.8. After 4 weeks of incubation in the dark at 27°C, the scutellar-derived callus was used for rice callus transformation. Calli were inoculated with an overnight culture of LBA4404 harboring pMJ103-LTB-CTB and were grown to an OD600 of 1.5–2.0 in AAM medium supplemented with 100 μM acetosyringone (Hiei et al. 1994). Co-cultivation was performed in the dark at 24°C for 7 days in half-strength Chu N6 medium supplemented with 10 g L−1 glucose, 100 μM acetosyringone, 2 mg L−1 2, 4-dichlorophenoxyacetic acid, and 3 g L−1 Phytagel at pH 5.2. After 5 weeks of incubation in the dark at 27°C, somatic embryogenic calli were transferred to regeneration medium [MS (MBcell) supplemented with 5 mg L−1 kinetin, 1 mg L−1 α-naphthalene acetic acid, 30 g L−1 sorbitol, 20 g L−1 maltose, 3 mg L−1 L-phosphinothricin, 250 mg L−1 cefotaxime, and 4 g L−1 Phytagel at pH 5.8. The developing plantlets were subsequently transferred to magenta boxes and stored in pots covered with polyethylene bags for 7–14 days, after which they were transferred to a greenhouse. PCR was performed to check the presence of each fragment (LTB and CTB) in the transformed Agrobacterium LBA4404 compared with the control.
Genomic DNA was extracted from fresh leaf tissues of putative transgenic plants using the DNA extraction kit (Bioneer, Korea) and purified after the RNase treatment, phenol-chloroform extraction, and ethanol precipitation. Purified DNA was analyzed using 0.8% agarose gel electrophoresis and quantified using the Nano-Drop 2000 (Thermo Scientific, U.S.A). Only high-quality genomic DNA was used for PCR and Southern blot analysis.
Primer sets used to confirm the presence of genes
Trait LL lateral flow test
Three rice seeds (wild-type and transgenic seeds) were ground and homogenized in 500 μl of ddH2O. After 5 min of decantation, the clear supernatant was immediately used in the lateral-flow assay.
Genomic DNA from the transgenic plants was digested with the XhoI restriction enzyme (2,000 U, Takara). The resulting fragments were fractionated on a 1% agarose gel, denatured, and transferred from the gel onto a Hybond H+ nylon membrane (Amersham Pharmacia Biotech) using the capillary transfer method (Sambrook and Russell 2006). The probe for the LTB gene was prepared by PCR from pMJ103-LTB-CTB. A total of 25 ng of LTB probe DNA were denatured at 100°C for 5 min. After cooling on ice for 5 min, denatured DNA was added to the mixture. After mixing with 5 μl of [α-32P] dCTP, probe DNA was incubated at 37°C for 10 min and labeled using Rediprime™ II Random Prime Labeling system (GE Healthcare). The reaction was terminated by adding 5 μl of 0.2 M Na-EDTA and the radiolabeled probe was purified using the PROBER™ Probe DNA purifying system (Intronbio, Korea). Purified labeled DNA was denatured by heating at 100°C for 5 min, stored on ice, and mixed with hybridization solution. Membranes were soaked in the pre-hybridization solution (6× SSC, 5× Denhardt’s reagent, 0.5% SDS and 100 μg/ml denatured fragmented salmon sperm DNA) at 65°C with gentle shaking. After 2 h, hybridization was performed in hybridization solution (6× SSC, 0.5% SDS and 100 μg/ml denatured fragmented salmon sperm DNA) containing the probe overnight at 65°C in a shaking incubator. After washing the membranes with the appropriate washing solutions and temperatures (2× SSC in 0.5% SDS at 25°C, 2× SSC in 0.1% SDS at 25°C, 0.1× SSC in 0.5% SDS at 37°C, 0.1× SSC in 0.5% SDS at 65°C, and 0.1× SSC), they were dried, covered in Saran wrap, and exposed to X-ray film (Kodak MS).
Total RNAs were isolated from rice seeds (150 mg) using TRIzol reagent according to the manufacturer’s instructions (Invitrogen, Breda, Netherlands). The RNA integrity was assessed under UV light by visualization of the 28S- and 18S-rRNA bands on a 1.5% agarose gel containing ethidium bromide. For reverse transcription (RT)-PCR analysis, total RNA samples were treated with DNase before reverse transcription, according to the manufacturer’s instructions (Takara). RT-PCR amplification was performed in a reaction mixture containing 1 μg total RNA, 1 × One Step RNA PCR buffer, 0.8 U RNase inhibitor, 0.4 μM of each primer, 0.1 U AMV RTase XL, 0.1 U AMV-optimized Taq DNA polymerase, 5 mM dNTP, and 5 mM MgCl2 (Takara). The reaction mixture was heated at 50°C for 30 min and 94°C for 2 min for reverse transcription and inactivation of reverse transcriptase, respectively. The reaction mixture was amplified by 35 cycles, each consisting of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C. After termination of the last cycle, the samples were incubated at 72°C for 10 min and chilled at 4°C. Specific primers were used for the amplification of LTB (LT-F and LT-R) and CTB (CT-F and CT-R), resulting in an amplified products of 107 and 111 bp, respectively. Actin-1 (GenBank accession number: KC140126) served as an internal control. Specific primers were used for the amplification of actin-1 (actin-F and actin-R), resulting in an amplified product of 150 bp. The amplified PCR products were electrophoresed on a 1% agarose gel containing ethidium bromide and photographed.
Flanking DNA sequencing and PCR of homozygous transgenic plants
Primers used for sequencing of flanking regions and selection of homozygous plants
The third−generation homozygous transgenic lines derived from LCI-7 and LCI-11 plants were analyzed by PCR of genomic DNA. The PCR was conducted with 0.5 pM of each primer to amplify the wild-type allele (RP1 and LP1; and RP2 and LP2), the T-DNA insertion allele (RP3 and BP1; and RP2 and BP2), and the second T-DNA insertion allele (LP1 and RB1; and LP2 and BP3). PCR was performed using a PTC-200 thermal cycler (MJ research) with the following reaction conditions: 95°C for 5 min, 30 cycles of 94°C for 30 s, 60°C for 1 min and 72°C for 1 min, followed by a final elongation at 72°C for 10 min.
Quantitative real-time PCR
qRT-PCR was performed in a 96-well format in the ABI 7500 Real-Time System (Applied Biosystems) with specific primers (designed using copy caller software) used to amplify a 100-bp fragment of LTB (LT-F and LT-R), CTB (CT-F and CT-R), Bar (bar-F and bar-R), and Tnos (Tnos-F and Tnos-R), as shown in Table 2. qRT-PCR was performed under the following conditions: 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. Three replicates were prepared from the same genomic DNA and the copy number of each gene. Expression levels of the CTB, LTB, Tnos and bar genes were normalized to that of α-tubulin as the reference gene.
GM1-ganglioside binding assay
Transgenic and wild-type rice seeds (2 g) were homogenized in 5 ml of buffer containing 0.1 M mM Tris–HCl (pH 8.0), 1 mM EDTA, 1 mM DTT, and 1× protease inhibitor cocktail (Sigma). Insoluble material was removed by centrifugation. Protein concentrations were determined using the Bradford protein assay reagent kit (Bio-Rad, Hercules, CA). The GM1-ganglioside binding capability of recombinant LTB and CTB proteins expressed in transgenic rice seeds was estimated based on ELISA. Briefly, a 96-well ELISA plate was coated with monosialoganglioside-GM1 (Santa Cruz Biotechnology) (3.0 μg ml−1 in sodium bicarbonate buffer) or BSA (3.0 μg ml−1 in sodium bicarbonate buffer) as a negative control, and incubated at 4°C overnight. Microwell strips were washed three times with approximately 200 μl of wash buffer per well. Wells were then blocked with 4% non-fat milk in PBS, washed three times with PBST and incubated with recombinant LTB (6.3 to 100 ng), authentic CTB (6.3 to 100 ng), or soluble protein from transgenic or untransformed rice seeds (4 μg) in PBS for 2 h at 37°C. Each well was then washed with PBS three times. Antisera against LTB (1:5,000 dilution) or CTB (1:5,000 dilution) in PBS buffer were added to each well and incubated for 2 h at 37°C, after which each well was washed with PBS three times. Goat anti-rabbit IgG polyclonal antiserum conjugated with AP (1:1,000 dilutions) in PBS buffer was then added to each well and incubated for 2 h at 37°C. After washing, 100 μl of p-nitrophenylacetate were added and the plate was incubated for 15 min. The enzyme reaction was stopped by quickly pipetting 50 μl of 2 N H2SO4 into each well. The absorbance at 405 nm was read using a microplate reader.
Western blot analysis
Transgenic rice seeds (2 g) were homogenized in 5 ml of extraction buffer containing 100 mM Tris–HCl (pH 8.0), 1 mM DTT, 1 mM EDTA, and 0.6 mM PMSF. Insoluble material was removed by centrifugation at 12,000 rpm for 20 min. Protein concentrations were determined using the Bradford Protein Assay Reagent kit (Bio-Rad) (Bradford 1976). Total soluble proteins (100 μg; the LTB protein accounted for 0.3 μg μg−1 of total soluble protein and CTB accounted for 2.1 μg μg−1 of total soluble protein) were mixed with sample buffer (10% glycerol, 60 mM Tris–HCl pH 6.8, 2% SDS, 0.01% bromophenol blue) at room temperature and were separated using 12% non-reducing SDS-polyacrylamide gel electrophoresis and then electrophoretically transferred to a PVDF membrane (iBlot™, Invitrogen) at a constant voltage of 150 V at room temperature for 40 min in a Bio-Rad mini trans-blot cell.
The electroblotting buffer was 10 mM CAPS-10% methanol. The membrane was blocked to prevent nonspecific antibody binding using 5% non-fat milk powder in Tween/Tris-buffered saline, and probed with a rabbit polyclonal antibody against LTB or CTB at 1:10,000 dilutions for 2 h at 37°C. After washing three times, the blot was probed with HRP-conjugated secondary antibodies (1:5,000) for 2 h. The ECL chemiluminescence reagent was added to the membrane as per the manufacturer’s instructions. The membrane was exposed to Chemi-Doc detection reagent (Bio-Rad) for 1 min before being developed and fixed.
Immunization of mice with transgenic rice seed extract
To investigate the immunogenicity of transgenic rice seeds (LCI-11), ten females BALB/c (5 weeks old) mice were administered with transgenic rice seed samples expressing both LTB and CTB. For the intraperitoneal immunization test, wild-type and transgenic rice seeds were ground and extracted in PBS. After quantifying soluble protein, test samples (100 μg in 100 μl PBS) were intraperitoneally injected into ten mice on day 1, followed by four booster injections on days 8, 15, 22, and 29. As positive controls, purified LTB (10 μg/mouse) and purified CTB (30 μg/mouse) expressed in E. coli as previous our report (Sim et al. 2009). To express CTB in E. coli, codon-optimized CTB gene was cloned at the N-terminus at Nde I site and at the C-terminus at Xho I (pET21a-CTB). The mice were divided into five groups (group 1, PBS; group 2, purified LTB; group 3, purified CTB; group 4, proteins from wild-type rice; group 5, proteins from transgenic rice) and were bled retro-orbitally every week until 5 weeks post-immunization. For oral immunization, wild-type and transgenic rice seeds were ground and suspended, and rice samples (100-mg rice powder/100-μl PBS) were orally ingested by mice on day 1 followed by eight further oral administrations on days 4, 7, 10, 13, 16, 19, 22, and 25. The amount of LTB and CTB in rice seed powders (100 mg) were approximately 90 and 110 μg, respectively. As positive controls, purified LTB (50 μg/mouse) expressed in E. coli was used. The mice were divided into four groups (group 1, PBS; group 2, purified LTB; group 3, wild-type rice seeds; group 4, transgenic rice seeds), and blood was sampled on day 28. Mice sera and feces were prepared, and the presence of specific antibodies to LTB and CTB was determined by ELISA. Briefly, a 96-well ELISA plate was coated with purified LTB or CTB (200 ng/well) in ELISA coating buffer (50 mM sodium bicarbonate-sodium carbonate, pH 9.6). The plate was incubated at 4°C overnight and washed with 200 μl of PBST (PBS-0.1% Tween-20) four times. The wells were then blocked with 4% non-fat milk in PBS at 37°C for 2 h. After washing the wells, diluted anti-sera (1:200, 1:1,000, 1:2,000, 1:4,000, 1: 10,000, 1:20,000, 1: 1,000,000 for intraperitoneal immunization or 1:100, 1:1,000, 1:10,000, 1: 100,000, 1: 1,000,000 for oral immunization, respectively) and diluted feces (1:100, 1:1,000, 1:10,000, 1: 100,000, 1: 1,000,000) were added to the wells and incubated at 37°C for 2 h. After washing, anti-mouse IgG-HRP (1:10,000 in both intraperitoneal and oral immunization tests) and anti-mouse IgA-HRP (1:10,000 in only oral immunization tests) were added to each well and incubated at 25°C for 1 h. After washing, 100 μl of TMB (3′, 3′, 5′, 5′-tetramethylbenzidine) containing H2O2 solution were added and the plate was incubated for 15 min at 37°C. The enzyme reaction was stopped by quickly pipetting 50 μl of 2 N H2SO4 into each well. The absorbance at 450 nm was read using a microplate reader.
Western blot analysis was performed for the detection of LTB- and CTB-specific IgG and IgA in mice sera after oral administration of LCI-11, respectively. Purified LTB or CTB proteins (50 ng) were loaded to 12% SDS-polyacrylamide gels with BSA (50 ng) as a negative control and then transferred to PVDF membranes. After blocking, membranes were probed with anti-sera (1:500) collected from mice immunized orally with LCI-11 at 4°C overnight, respectively. After washing, the blots were probed with HRP-conjugated secondary antibodies (1:1,000) for 2 h at 37°C. Membranes were developed by using the ECL reagent as the manufacturer’s protocol.
This project was supported by a grant from Gyeonggido Agricultural Research & Extension Services and the National Academy of Agricultural Science (PJ01086903), RDA, Korea. This study was supported by 2014 Postdoctoral Fellowship Program (to H.Y.C, H.A. and I.C.) of the National Academy of Agricultural Science, RDA, Korea.
- Ahrén C, Wennerås C, Holmgren J, Svennerholm AM (1993) Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine 11(9):929–935View ArticleGoogle Scholar
- Arakawa T, Chong DKX, Merritt JL, Langridge WHR (1997) Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res 6(6):403–413View ArticleGoogle Scholar
- Archer DB (1994) Enzyme production by recombinant Aspergillus. In: Murooka Y, Imanaka T (eds) Recombinant Microbes for Industrial and Agricultural Applications. Marcel Dekker Inc, New YorkGoogle Scholar
- Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(1–2):248–254View ArticleGoogle Scholar
- Chen R (2012) Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol Adv 30(5):1102–1107View ArticleGoogle Scholar
- Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11(5):479–493View ArticleGoogle Scholar
- Clemens JD, Van Loon F, Sack DA, Rao MR, Ahmed F, Harris JR, Khan MR, Yunus M, Huda S (1991) Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis 163(6):1235–1242View ArticleGoogle Scholar
- Cui L, Chen Y, Shen G, Zhao L, Tang K (2011) Expression of bioactive thymosin alpha 1 (Tα1) in marker-free transgenic lettuce (lactuca sativa). Plant Mol Biol Rep 29(2):466–472View ArticleGoogle Scholar
- Dong J, Teng W, Buchholz WC, Hall TC (1996) Agrobacterium-mediated transformation of javanica rice. Mol Breed 2(3):267–276View ArticleGoogle Scholar
- Du G-L, Song C-Z, Zhang G-L, Sun X-G, Liu D-R (2005) Transgenic Lycium barbarum L. Established as HIV capsid protein expression system. Plant Mol Biol Report 23(4):411–416View ArticleGoogle Scholar
- El Adab SM, Ezzine A, Khedija IB, Chouchane L, Marzouki MN (2007) Expression of human papillomavirus type 16 major capsid protein L1 in transgenic Arabidopsis thaliana. Plant Mol Biol Rep 25(3–4):133–144View ArticleGoogle Scholar
- Guo Q-Q, Zhang Z-L, Jiang S-J, Ma J-T, Xue W-T, Wu Y-M (2012) Expression of an avian influenza virus (H5N1) hemagglutinin gene in transgenic lotus corniculatus. Plant Mol Biol Rep 30(5):1117–1124View ArticleGoogle Scholar
- Guzman GD, Walmsley AM, Webster DE, Hamill JD (2011) Hairy roots cultures from different Solanaceous species have varying capacities to produce E. coli B-subunit heat-labile toxin antigen. Biotechnol Lett 33(12):2495–2502View ArticleGoogle Scholar
- Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268(5211):714–716View ArticleGoogle Scholar
- Harashima S (1994) Heterologous protein production by yeast host-vector systems. Bioprocess Technol 19:137–158Google Scholar
- Hiei Y, Ohta S, Komari T, Kumashiro T (1994) Efficient transformation of rice (Oryza sativa L.) mediated by Agrobacterium and sequence analysis of the boundaries of the T-DNA. Plant J 6(2):271–282View ArticleGoogle Scholar
- Jani D, Meena LS, Rizwan-ul-Haq QM, Singh Y, Sharma AK, Tyagi AK (2002) Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res 11(5):447–454View ArticleGoogle Scholar
- Jani D, Singh NK, Bhattacharya S, Meena LS, Singh Y, Upadhyay SN, Sharma AK, Tyagi AK (2004) Studies on the immunogenic potential of plant-expressed cholera toxin B subunit. Plant Cell Rep 22(7):471–477View ArticleGoogle Scholar
- Kajiura H, Wasai M, Kasahara S, Takaiwa F, Fujiyama K (2013) N-glycosylation and N-glycan moieties of CTB expressed in rice seeds. Mol Biotechnol 54(3):784–794View ArticleGoogle Scholar
- Kang TJ, Loc NH, Jang MO, Jang YS, Kim YS, Seo JE, Yang MS (2003) Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res 12(6):683–691View ArticleGoogle Scholar
- Karaman S, Cunnick J, Wang K (2012) Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler’s diarrhea. Plant Cell Rep 31(3):527–537View ArticleGoogle Scholar
- Kim TG, Kim MY, Kim BG, Kang TJ, Kim YS, Jang YS, Arntzen CJ, Yang MS (2007) Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa). Protein Expr Purif 51(1):22–27View ArticleGoogle Scholar
- Kim YS, Kim MY, Kim TG, Yang MS (2009) Expression and assembly of cholera toxin B subunit (CTB) in transgenic carrot (Daucuscarota L.). Mol Biotechnol 41(1):8–14View ArticleGoogle Scholar
- Kim TG, Kim BG, Kim MY, Choi JK, Jung ES, Yang MS (2010) Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus. Mol Biotechnol 44(1):14–21View ArticleGoogle Scholar
- Kim MY, Kim TG, Yoo HS, Yang MS (2011) Expression and assembly of ApxIIA toxin of Actinobacillus pleuropneumoniae fused with the enterotoxigenic E. coli heat-labile toxin B subunit in transgenic tobacco. Plant Cell Tiss Organ Cult 105(3):375–382View ArticleGoogle Scholar
- Ko SM, Yoo BH, Lim JM, Oh KH, Liu JI, Kim SW, Liu JR, Choi KS, Yoon ES (2009) Production of fibrinolytic enzyme in plastid-transformed tobacco plants. Plant Mol Biol Rep 27(4):448–453View ArticleGoogle Scholar
- Lebens M, Johansson S, Osek J, Lindblad M, Holmgren J (1993) Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Biogeosciences 11(13):1574–1578Google Scholar
- Lebens M, Shahabi V, Bäckström M, Houze T, Lindblad N, Holmgren J (1996) Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine. Infect Immun 64(6):2144–2150Google Scholar
- Ma JKC, Drake PMW, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805View ArticleGoogle Scholar
- Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16(13):1336–1343View ArticleGoogle Scholar
- Mattanovich D, Branduardi P, Dato L, Gasser B, Sauer M, Porro D (2012) Recombinant protein production in yeasts. Methods Mol Biol 824:329–358View ArticleGoogle Scholar
- Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A 104(26):10986–10991View ArticleGoogle Scholar
- Notaro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11(1):142–201Google Scholar
- Oszvald M, Kang TJ, Tomoskozi S, Jenes B, Kim TG, Cha YS, Tamas L, Yang MS (2008) Expression of cholera toxin B subunit in transgenic rice endosperm. Mol Biotechnol 40(3):261–268View ArticleGoogle Scholar
- Prokop A, Bajpai RK, Ho CS (1991) Recombinant DNA technology and applications. McGraw Hill, New YorkGoogle Scholar
- Rosales-Mendoza S, Soria-Guerra RE, Olivera-Flores MTJ, López-Revilla R, Argüello-Astorga GR, Jiménez-Bremont JF, Cruz RFG, Loyola-Rodríguez JP, Alpuche-Solís ÁG (2007) Expression of Escherichia coli heat-labile enterotoxin b subunit (LTB) in carrot (Daucus carota L.). Plant Cell Rep 26(7):969–976View ArticleGoogle Scholar
- Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solîs ÁG (2008) Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 27(1):79–84View ArticleGoogle Scholar
- Sambrook J, Russell DW (2006) Southern Blotting: Capillary Transfer of DNA to Membranes. Cold Spring Harbour Protocol, New YorkGoogle Scholar
- Schonberger O, Hirst TR, Pines O (1991) Targeting and assembly of an oligomeric bacterial enterotoxoid in the endoplasmic reticulum of Saccharomyces cerevisiae. Mol Microbiol 5(11):2663–2671View ArticleGoogle Scholar
- Sim J-S, Pak H-K, Kim D-S, Lee S-B, Kim Y-H, Hahn B-S (2009) Expression and characterization of synthetic heat-labile enterotoxin B subunit and hemagglutinin–neuraminidase-neutralizing epitope fusion protein in Escherichia coli and tobacco chloroplasts. Plant Mol Biol Rep 27(3):388–399View ArticleGoogle Scholar
- Streatfield SJ, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, Woodard SL, Beifuss KK, Horn ME, Delaney DE, Tizard IR, Howard JA (2001) Plant-based vaccines: unique advantages. Vaccine 19(17–19):2742–2748View ArticleGoogle Scholar
- Streatfield SJ, Mayor JM, Barker DK, Brooks C, Lamphear BJ, Woodard SL, Beifuss KK, Vicuna DV, Massey LA, Horn MA, Delaney DE, Nikolov ZL, Hood EE, Jilka JM, Howard JA (2002) Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. Vitro Cell Dev Biol Plant 38(1):11–17View ArticleGoogle Scholar
- Sue MP, Mariana LF, Brian M, Linda MH (2005) Heterologous protein production using the Pichiapastoris expression system. Yeast 22(4):249–270View ArticleGoogle Scholar
- Svennerholm AM, Holmgren J, Black R, Levine M, Merson M (1983) Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis 147(3):514–522View ArticleGoogle Scholar
- Svennerholm AM, Wikström M, Lindblad M, Holmgren J (1986) Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med Biol 64(1):23–30Google Scholar
- Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22(31–32):4385–4389View ArticleGoogle Scholar
- Terpe K (2006) Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72(2):211–222View ArticleGoogle Scholar
- Tingfeng L, Yuansheng Y, Say KN (2013) Advances in mammalian cell line development technologies for recombinant protein production. Pharmaceuticals 6(5):579–603View ArticleGoogle Scholar
- Tokuhara D, Yuki Y, Nochi T, Kodama T, Mejima M, Kurokawa S, Takahashi Y, Nanno M, Nakanishi U, Takaiwa F, Honda T, Kiyono H (2010) Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci U S A 107(19):8794–8799View ArticleGoogle Scholar
- Unni SC, Soniya EV (2010) Transgenic cucumis sativus expressing the hepatitis B surface antigen. Plant Mol Biol Rep 28(4):627–634View ArticleGoogle Scholar
- Williams NA, Hirst TR, Nashar TO (1999) Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol Today 20(2):95–101View ArticleGoogle Scholar
- Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22(11):1393–1398View ArticleGoogle Scholar
- Yang L, Wakasa Y, Takaiwa F (2008) Biopharming to increase bioactive peptides in rice seed. J AOAC Int 91(4):957–964Google Scholar
- Yuki Y, Kiyono H (2009) Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines 8(8):1083–1097View ArticleGoogle Scholar
- Yuki Y, Mejima M, Kurokawa S, Hiroiwa T, Takahashi Y, Tokuhara D, Nochi T, Katakai Y, Kuroda M, Takeyama N, Kashima K, Abe M, Chen Y, Nakanishi U, Masumura T, Takeuchi Y, Kozuka-Hata H, Shibata H, Oyama M, Tanaka K, Kiyono H (2013) Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification. Plant Biotechnol J 11(7):799–808View ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.